Study how gut lining heals in inflammatory bowel disease
Part of Bones, joints & muscles, Digestive system, Immune system & allergy, Injuries & trauma, Skin clinical trials.
This study looks at how the lining of the colon heals in people with inflammatory bowel disease (ulcerative colitis or Crohn’s disease). It may help researchers understand whether anti-TNF treatment improves healing, especially when people have limited prior response or are starting biologic therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis or Crohn’s disease (or have rheumatoid/psoriatic arthritis for a separate study group).
- For ulcerative colitis/Crohn’s: you are either new to biologic (anti-TNF) treatment or your current biologic treatment has stopped working (biologic failure).
- You must be eligible to receive anti-TNF therapy.
- If you have rheumatoid or psoriatic arthritis: you must already be taking an anti-TNF medicine.
- You are not pregnant, not on blood thinners (except low-dose aspirin), and you are not on steroid medicine or metformin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.